Increased risk weighs on GENESIS HEALTHCARE INCO., penalising its rating down to Slightly Negative
The independent financial analyst theScreener just lowered the general evaluation of GENESIS HEALTHCARE INCO. (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date March 20, 2020, the closing price was USD 0.79 and its target price was estimated at USD 0.75.Genesis Healthcare is a holding company. The company's services focus primarily on the medical and physical issues facing elderly patients and are provided by its nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services. The company's reportable operating segments comprised of: inpatient services, which includes the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy services, which includes the company's third-party rehabilitation and respiratory therapy services; and other services, which provides a range of other medical services, including physician services.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.